DEFEAT MALARIA DEFEAT MALARIA ACTIV ITY QUARTERLY PERFORMANCE REPORT FISCAL YEAR 2019 QUARTER 2 (JANUARY 1, 2019 TO MARCH 31, 2019) 2019 QUARTER 2 PERFORMANCE REPORT Submission Date: April 30, 2019 Agreement Number: AID-482-A-16-00003 Agreement Period: August 15, 2016 to August 14, 2021 AOR Name: Dr. Feliciano Monti Submitted by: May Aung Lin, Chief of Party University Research Co., LLC. Room 602, 6th Floor, Shwe Than Lwin Condominium New University Ave. Rd., BahanTownship Yangon, Myanmar Email: [email protected] CONTACT INFORMATION Dr. May Aung Lin, Chief of Party, Defeat Malaria [email protected] Office Phone/Fax: + 95 1 559 593, + 011 220 658, Mobile: + 959 7324 1930 Dr. Saw Lwin, Regional Technical Director, Defeat Malaria [email protected] Office Phone/Fax: + 95 1 559 593, + 011 220 658, Mobile: + 959 5014 887 THIS DOCUMENT WAS PRODUCED BY UNIVERSITY RESEARCH CO., LLC (URC) FOR REVIEW AND APPROVAL BY THE UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT (USAID). DEFEAT MALARIA Defeat Malaria is a USAID-funded project with the goal to reduce the malaria burden and control artemisinin- resistant malaria in the targeted areas, thereby contrib- uting to the long-term national goal of eliminating ma- laria in Myanmar. Defeat Malaria has four core objec- tives, including: Objective 1: Achieve and maintain universal cover- age of at-risk populations with proven vector control and case management interventions, while pro- moting the testing of new tools and approaches. Objective 2: Strengthen the malaria surveillance sys- tem to comprehensively monitor progress and in- form the deployment and targeting of appropriate responses and strategies. Objective 3: Enhance technical and operational ca- pacity of the NMCP and other health service provid- ers at all levels of service provision. Objective 4: Promote the involvement of communi- ties, private healthcare providers, private companies and state-owned enterprises in malaria control and elimination initiatives. DEFEAT MALARIA FY2019 Q2 OUTCOMES Testing & Case Finding 61,817 people were tested for malaria Health Communication 46,468 people, including 7,422 of whom migrants, were reached through 721 were positive cases interpersonal communication Total Positivity Rate: 1.17% Treatment Completion Preventive Commodities 510 individuals were Distributed 80,515 LLINs enrolled in DOT treatment; to villages, worksites, and 97.8% of enrolled cases women attending completed DOT treatment ante-natal care clinics Diagnostic and Treatment Commodities Capacity Building Distributed 114,175 RDTs 2,022 health workers and 8,144ACTs received refresher to Defeat Malaria storage trainings on malaria sites to safeguard diagnostics and case continuous and on-time management delivery of malaria health care services DEFEAT MALARIA QUARTERLY PERFORMANCE REPORT FY2019 Q2 Table of Contents ACRONYMS AND ABBREVIATIONS ...................................................................................................................... II EXECUTIVE SUMMARY ....................................................................................................................................... 1 INTRODUCTION.................................................................................................................................................. 2 OBJECTIVE 1: ACHIEVE AND MAINTAIN UNIVERSAL COVERAGE OF AT-RISK POPULATIONS WITH PROVEN VECTOR CONTROL AND CASE MANAGEMENT INTERVENTIONS, WHILE PROMOTING THE TESTING OF NEW TOOLS AND APPROACHES. .............................................. 4 OBJECTIVE 2: STRENGTHEN THE MALARIA SURVEILLANCE SYSTEM TO COMPREHENSIVELY MONITOR PROGRESS AND INFORM THE DEPLOYMENT AND TARGETING OF APPROPRIATE RESPONSES AND STRATEGIES. .......................................................................... 12 OBJECTIVE 3: ENHANCE TECHNICAL AND OPERATIONAL CAPACITY OF THE NMCP AND OTHER HEALTH SERVICE PROVIDERS AT ALL LEVELS OF SERVICE PROVISION ................................................................................................................................................... 15 OBJECTIVE 4: PROMOTE THE INVOLVEMENT OF COMMUNITIES, PRIVATE HEALTHCARE PROVIDERS, PRIVATE COMPANIES AND STATE- OWNED ENTERPRISES IN MALARIA CONTROL AND ELIMINATION INITIATIVES .............................................................................. 18 ANNEXES .......................................................................................................................................................... 21 ANNEX 1: SITUATION IN RAKHINE STATE ........................................................................................................................... 21 ANNEX 2: SUCCESS STORIES ........................................................................................................................................... 22 ANNEX 3: ENTOMOLOGICAL SURVEY ON PERSISTANT MALARIA TRANSMISSION METHODS AND FINDINGS ....................................... 25 ANNEX 4: CASE FINDING AND MANAGEMENT .................................................................................................................... 26 ANNEX 5-A: ACTIVE CASE DETECTION BY MOBILE TEAM (PROJECT VILLAGES) ........................................................................... 28 ANNEX 5-B: ACTIVE CASE DETECTION BY MOBILE TEAM (NON-PROJECT VILLAGES) ................................................................... 29 ANNEX 6: MONTHLY MEETINGS ..................................................................................................................................... 30 ANNEX 7: SUPERVISION AND MONITORING ........................................................................................................................ 32 ANNEX 8: REPORTING STATUS OF VMWS/PPS .................................................................................................................. 33 ANNEX 9: CLINICAL AUDIT .............................................................................................................................................. 35 ANNEX 10: STOCK OUT MONITORING AT THE TIME OF MONITORING VISITS .............................................................................. 37 ANNEX 11: CAPACITY BUILDING ...................................................................................................................................... 39 ANNEX 12: BEHAVIOR CHANGE COMMUNICATION ............................................................................................................. 41 ANNEX 13: ADVOCACY MEETINGS ................................................................................................................................... 43 ANNEX 14: STRATEGIES TO ADDRESS MID-TERM EVALUATION RECOMMENDATIONS ................................................................. 44 ANNEX 15: PERFORMANCE INDICATORS ........................................................................................................................... 48 Figure 1: Geographic spread of Defeat Malaria activities in Myanmar as of March 2019 ........................... 2 Figure 2: RDT Distribution from the Central Warehouse to State/Region and EHO (Jan-Mar 2019) ........... 4 Figure 3: ACT Distribution from the Central Warehouse to State/Region and EHO (Jan-Mar 2019) ........... 4 Figure 4: Reporting status of VMWs/PPs by State and Region ..................................................................... 8 Figure 5: Malaria testing and diagnosis by source for FY19 Q2 .................................................................... 9 Figure 6: Routine Data Quality Assessment Status, Jan-March 2019 ......................................................... 13 Figure 7: Foci Classification based on 2018 surveillance data .................................................................... 15 Table 1: Project area coverage as of September 30, 2018 ........................................................................... 3 Table 2: Long lasting insecticide net (LLIN) distribution at villages (Jan-Mar 2019) ..................................... 6 Table 3: LLIN distribution at worksites (Jan-Mar 2019) ................................................................................ 6 Table 4: LLIN Coverage and Utilization by Defeat Malaria State/Region (Jan-Mar 2019) ............................ 7 Table 5: Malaria testing by Defeat Malaria covered state/region (Jan-Mar 2019) ...................................... 9 Table 6: Findings of hsRDT study in Rakhine State ..................................................................................... 11 Table 7: Malaria Elimination Capacity Building Training ............................................................................ 16 Page | i DEFEAT MALARIA QUARTERLY PERFORMANCE REPORT FY2019 Q2 Acronyms and Abbreviations ABER Annual Blood Examination Rate ACD Active case detection ACT Artemisinin-based combination therapy ANC Antenatal Care API Annual Parasite Incidence ARC American Refugee Committee ASTMH American Society of Tropical Medicine and Hygiene BCC Behavior Change Communication BHS Basic Health Staff BPHWT Back Pack Health Worker Team CBO Community based organization CDC Centers for Disease Control and Prevention COP Chief of Party cRDT Conventional rapid diagnostic test CSG Community Support Group C-sum Cumulative sum DHF Dengue Hemorrhagic Fever DMR Department of Medical Research DOT Directly Observed Treatment DQO Data Quality Officer EHO Ethnic Health Organization EID Emerging infectious diseases ELISA Enzyme-linked immunosorbent